Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
atazanavir (reyataz) (1 trial)
raltegravir (isentress) (1 trial)
ritonavir (Norvir) (1 trial)
Hepatitis C (Phase 4)
Trials (1 total)
Trial APIs (3 total)